​

Tenax Therapeutics (TENX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Tenax Therapeutics Revenue Highlights

00

Tenax Therapeutics Revenue by Period

Tenax Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--100.00%
2015-04-30$49.29K-82.93%
2014-04-30$288.73K-76.60%
2013-04-30$1.23M197.33%
2012-04-30$415.03K28.75%
2011-04-30$322.35K47.07%
2010-04-30$219.18K100.00%
2009-04-30-100.00%
2008-04-30--100.00%
2007-04-30$-24.13K-5.86%
2006-04-30$-25.63K-
2005-04-30$-25.63K100.00%
2004-04-30-100.00%
2003-04-30-100.00%
2002-04-30--100.00%
2001-04-30$1.00-
2000-04-30$1.00-100.00%
1999-04-30$100.00K100.00%
1998-04-30-100.00%
1997-04-30-100.00%
1996-04-30--

Tenax Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Tenax Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$2.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$5.79K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31$21.22K100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-10-31-100.00%
2015-07-31--100.00%
2015-04-30$49.29K100.00%
2015-01-31-100.00%
2014-10-31-100.00%
2014-07-31--100.00%
2014-04-30$-5.92K-114.01%
2014-01-31$42.27K-28.42%
2013-10-31$59.06K-69.45%
2013-07-31$193.31K-7.11%
2013-04-30$208.10K-7.06%
2013-01-31$223.92K-57.27%
2012-10-31$524.01K88.49%
2012-07-31$278.01K180.46%
2012-04-30$99.12K-34.26%
2012-01-31$150.77K42.70%
2011-10-31$105.66K77.65%
2011-07-31$59.48K-73.78%
2011-04-30$226.81K331.50%
2011-01-31$52.56K45.67%
2010-10-31$36.08K100.00%
2010-07-31-100.00%
2010-04-30-100.00%
2010-01-31-100.00%
2009-10-31-100.00%
2009-07-31-100.00%
2009-04-30-100.00%
2009-01-31-100.00%
2008-10-31-100.00%
2008-07-31-100.00%
2008-04-30--

Tenax Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Tenax Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VRCAVerrica Pharmaceuticals$7.57M$14.34M
SABSSAB Biotherapeutics$2.24M-
PLURPluri$1.34M$427.00K
QTTBQ32 Bio$1.16M-
ANTXAN2 Therapeutics--
BOLDBoundless Bio--
TENXTenax Therapeutics--
NXTCNextCure--
NERVMinerva Neurosciences--
JSPRJasper Therapeutics--
PSTVPlus Therapeutics--

TENX Revenue FAQ

What is Tenax Therapeutics’s yearly revenue?

Tenax Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. TENX's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Tenax Therapeutics’s quarterly revenue?

Tenax Therapeutics's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). TENX's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Tenax Therapeutics’s revenue growth rate?

Tenax Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.